ARCHIVES

NCI-Approved CTEP Trials For the Month of September

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987

New Research Training Act May Permit NCI To Help fill Clinical Gaps In Radiotherapy, Medical Oncology

July 26, 1974

Moses To Lead AACI.

October 19, 2001

NIGMS Hosts Meeting On Increasing Minorities In Biomedical Careers

December 1, 1995

NCI Advisory Group, other Cancer Meetings

July 29, 1988